Cynata Therapeutics Limited (CYP.AX)
AUD 0.2
(0.0%)
AUD 0.2
(0.0%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 | 108.2 Thousand AUD | -356900.0% |
| 2023 | 1.00 AUD | 0.0% |
| 2022 | - AUD | 0.0% |
| 2021 | - AUD | 0.0% |
| 2020 | - AUD | 100.0% |
| 2019 | -63.47 Thousand AUD | -20.48% |
| 2018 | -52.68 Thousand AUD | 39.93% |
| 2017 | -87.7 Thousand AUD | -60.48% |
| 2016 | -54.65 Thousand AUD | -14.32% |
| 2015 | -47.8 Thousand AUD | -400.76% |
| 2014 | -9547.00 AUD | 71.3% |
| 2013 | -33.26 Thousand AUD | 0.0% |
| 2012 | - AUD | -100.0% |
| 2011 | 307.64 Thousand AUD | 0.0% |
| 2010 | - AUD | 0.0% |
| 2009 | - AUD | 0.0% |
| 2008 | - AUD | -100.0% |
| 2007 | 105.88 Thousand AUD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | - AUD | 0.0% |
| 2024 Q4 | 108.2 Thousand AUD | 0.0% |
| 2024 FY | - AUD | -100.0% |
| 2023 FY | 1.00 AUD | 0.0% |
| 2023 Q4 | 1.00 AUD | 0.0% |
| 2023 Q2 | - AUD | 0.0% |
| 2022 Q2 | - AUD | 0.0% |
| 2022 FY | - AUD | 0.0% |
| 2022 Q4 | - AUD | 0.0% |
| 2021 Q2 | - AUD | 0.0% |
| 2021 Q4 | - AUD | 0.0% |
| 2021 FY | - AUD | 0.0% |
| 2020 Q4 | - AUD | 0.0% |
| 2020 FY | - AUD | 100.0% |
| 2020 Q2 | - AUD | 0.0% |
| 2019 Q2 | - AUD | 0.0% |
| 2019 FY | -63.47 Thousand AUD | -20.48% |
| 2019 Q4 | -63.47 Thousand AUD | 0.0% |
| 2018 FY | -52.68 Thousand AUD | 39.93% |
| 2018 Q2 | - AUD | 0.0% |
| 2018 Q4 | -56.25 Thousand AUD | 0.0% |
| 2017 Q2 | - AUD | 0.0% |
| 2017 Q4 | -91.27 Thousand AUD | 0.0% |
| 2017 FY | -87.7 Thousand AUD | -60.48% |
| 2016 Q2 | - AUD | 0.0% |
| 2016 Q4 | -58.22 Thousand AUD | 0.0% |
| 2016 FY | -54.65 Thousand AUD | -14.32% |
| 2015 Q2 | - AUD | 0.0% |
| 2015 Q4 | -47.8 Thousand AUD | 0.0% |
| 2015 FY | -47.8 Thousand AUD | -400.76% |
| 2014 FY | -9547.00 AUD | 71.3% |
| 2014 Q2 | - AUD | 0.0% |
| 2014 Q4 | -9547.00 AUD | 0.0% |
| 2013 Q2 | - AUD | 0.0% |
| 2013 FY | -33.26 Thousand AUD | 0.0% |
| 2013 Q4 | -33.26 Thousand AUD | 0.0% |
| 2013 Q3 | - AUD | 100.0% |
| 2013 Q1 | - AUD | 0.0% |
| 2012 FY | - AUD | -100.0% |
| 2012 Q4 | - AUD | 0.0% |
| 2011 Q4 | 307.64 Thousand AUD | 0.0% |
| 2011 FY | 307.64 Thousand AUD | 0.0% |
| 2010 FY | - AUD | 0.0% |
| 2010 Q4 | - AUD | 0.0% |
| 2009 FY | - AUD | 0.0% |
| 2009 Q4 | - AUD | 0.0% |
| 2008 Q4 | - AUD | 0.0% |
| 2008 FY | - AUD | -100.0% |
| 2007 FY | 105.88 Thousand AUD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| AdAlta Limited | -1.67 Million AUD | 106.443% |
| Acrux Limited | 147 Thousand AUD | 26.392% |
| Actinogen Medical Limited | 108.82 Thousand AUD | 0.574% |
| AnteoTech Limited | 221.85 Thousand AUD | 51.228% |
| Argenica Therapeutics Limited | - AUD | -Infinity% |
| Arovella Therapeutics Limited | - AUD | -Infinity% |
| Anatara Lifesciences Ltd | -671.09 Thousand AUD | 116.124% |
| Alterity Therapeutics Limited | 1.00 AUD | -10820300.0% |
| Amplia Therapeutics Limited | - AUD | -Infinity% |
| Avecho Biotechnology Limited | 97.11 Thousand AUD | -11.416% |
| Bio-Gene Technology Limited | - AUD | -Infinity% |
| Biome Australia Limited | 1.88 Million AUD | 94.271% |
| Biotron Limited | - AUD | -Infinity% |
| Botanix Pharmaceuticals Limited | 1.2 Million AUD | 91.053% |
| BTC Health Limited | - AUD | -Infinity% |
| Chimeric Therapeutics Limited | - AUD | -Infinity% |
| CSL Limited | 8.93 Billion AUD | 99.999% |
| Clarity Pharmaceuticals Ltd | - AUD | -Infinity% |
| Clinuvel Pharmaceuticals Limited | 10.62 Million AUD | 98.982% |
| Dimerix Limited | - AUD | -Infinity% |
| EZZ Life Science Holdings Limited | 1.4 Million AUD | 92.278% |
| Hexima Limited | - AUD | -Infinity% |
| Island Pharmaceuticals Limited | -877.24 Thousand AUD | 112.335% |
| Immuron Limited | 1.58 Million AUD | 93.172% |
| Immutep Limited | 2.00 AUD | -5410100.0% |
| Imugene Limited | - AUD | -Infinity% |
| Invex Therapeutics Ltd | -94.98 Thousand AUD | 213.919% |
| Memphasys Limited | 164.76 Thousand AUD | 34.327% |
| Nanollose Limited | - AUD | -Infinity% |
| Neuren Pharmaceuticals Limited | - AUD | -Infinity% |
| Noxopharm Limited | -2.35 Million AUD | 104.586% |
| NeuroScientific Biopharmaceuticals Limited | - AUD | -Infinity% |
| Nyrada Inc. | - AUD | -Infinity% |
| Orthocell Limited | 1.17 Million AUD | 90.804% |
| PharmAust Limited | - AUD | -Infinity% |
| Patrys Limited | - AUD | -Infinity% |
| Paradigm Biopharmaceuticals Limited | - AUD | -Infinity% |
| Proteomics International Laboratories Limited | - AUD | -Infinity% |
| Prescient Therapeutics Limited | - AUD | -Infinity% |
| PYC Therapeutics Limited | -17.99 Million AUD | 100.601% |
| Race Oncology Limited | 16.4 Thousand AUD | -559.74% |
| Radiopharm Theranostics Limited | -987.41 Thousand AUD | 110.958% |
| Recce Pharmaceuticals Ltd | - AUD | -Infinity% |
| Starpharma Holdings Limited | 2.4 Million AUD | 95.506% |
| Telix Pharmaceuticals Limited | 17.31 Million AUD | 99.375% |
| Tissue Repair Ltd | 214.72 Thousand AUD | 49.607% |
| Zelira Therapeutics Limited | 1.25 Million AUD | 91.36% |